Gilles de la Tourette's disease and minimal brain dysfunction: amphetamine isomers reveal catecholamine correlates in an affected patient.
D000661:Amphetamine / Q000627:therapeutic use*; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications / Q000188:drug therapy*; D001921:Brain / Q000378:metabolism; D002648:Child; D003913:Dextroamphetamine / Q000627:therapeutic use*; D004298:Dopamine / Q000378:metabolism; D005260:Female; D006801:Humans; D009638:Norepinephrine / Q000378:metabolism; D005879:Tourette Syndrome / Q000150:complications / Q000188:drug therapy*
D000661:Amphetamine; D003913:Dextroamphetamine; D004298:Dopamine; D009638:Norepinephrine